Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

Filter your results:

Types

Topics

95 Results Found

Member

340B Advocacy Alliance Bulletin: AHA Urges HHS to Ensure Hospitals Can Remain in 340B Program

The AHA today urged the Department of Health and Human Services to ensure hospitals currently participating in the 340B Drug Pricing Program continue to have access to the program despite changes in their payer mix as a result of the COVID-19 public health emergency.
Member

AHA 340B Advocacy Alliance Bulletin: AHA Expresses Support for Bill that Would Provide Certainty for 340B Hospitals

The AHA yesterday
Member

340B AHA Advocacy Alliance Bulletin: News and Resources on the 340B Program

Member

340B Advocacy Alliance Bulletin: Last Chance to Register for Today’s 340B Alliance Call at 3 p.m. ET

The AHA 340B Advocacy Alliance today, Feb.
Member

340B Advocacy Alliance Bulletin: California court dismisses 340B case without prejudice allowing hospitals to refile case

A U.S.
Member

340B Advocacy Alliance Bulletin: Register for Monday, Feb. 22, 340B Alliance Call to Hear Legislative and Legal Updates

The AHA 340B Advocacy Alliance Feb. 22 at 3 p.m. ET will provide an update on the many legal cases and issues surrounding the 340B Drug Pricing Program.
Member

340B Advocacy Alliance Bulletin: AHA, Others Ask U.S. Supreme Court to Hear Cases on 340B, Hospital Outpatient Cuts

The AHA, joined by member hospitals and health system
Member

340B Advocacy Alliance Bulletin: Deadline Extended to Feb. 18 to Get Representatives to Sign onto 340B ‘Dear Colleague’ Letter

Please contact your representatives and ask them to s
Member

Urge Your Representatives to Sign onto ‘Dear Colleague’ Letter to Xavier Becerra, Asking Him to Protect 340B

Please contact your representatives today and ask them to sign onto a bipartisan “Dear Colleague” letter to Xavier Becerra, the nominee for Department of Health and Human Services Secretary, asking him to take immediate action to ensure that manufacturers are prohibited from imposing unilateral changes to the 340B Drug Pricing Program that are in direct conflict with congressional intent and decades of written guidance. 
Member

340B Advocacy Alliance Bulletin: Drug Manufacturers Urged to Provide Discounts to 340B Community Pharmacies

Yesterday counsel for AHA and the four other national groups participants and three individual hospital systems that